Skip to main content
Equibles
ABUS logo

ABUS · Arbutus Biopharma Corp · Share Buybacks

Track ABUS — free

Use ABUS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ABUS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.67 +0.22 (+4.94%) At close · Oct 5
Russell 2000 member Rebalance outlook locked
Market Cap
$958.57M
Shares
197.85M
Volume · Oct 5 6.18M Avg daily vol (3M) 4.58M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$230,000,000
as of 2026-08-21 · from 8-K (reviewed)· expired 2026-09-29
Program Announced Authorized Remaining Runs Through
2026-08-21 $230,000,000 — 2026-09-29 expired
2026-07-16 $230,000,000 — —
Key facts CIK 1447028 CUSIP 03879J100 13F (30d) 3 filings 3 filers Visit website Investor relations